EREG and cholangiocarcinoma: Tumor promotion characteristics of CD16 + monocytes were identified in cholangiocarcinoma patients with higher expression of adhesion molecules (CD11c, CD163) and angiogenic factor-related genes (VEGF-A, epiregulin)7.